Synapse - Works

Results (4925)

Galinpepimut-S, a WT1-targeting immuno-oncology treatment, induces specific, robust and durable immune responses (IRs) in patients (Pts) with high-risk (HR) multiple myeloma (MM)

Meeting Abstract

Koehne, G.; Devlin, S.; Korde, N.; Mailankody, S.; Heather, L.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Sarlis, N.; more...
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

The genomic landscape of leukemic transformation of myeloproliferative neoplasm

Meeting Abstract

Menghrajani, K.; Rapaport, F.; Famulare, C.; Patel, M.; Manshouri, T.; Verstovsek, S.; Levine, R.; Rampal, R.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Management of important adverse events associated with inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia

Meeting Abstract

Kebriaei, P.; van Besien, K.; Cutler, C.; de Lima, M.; Giralt, S.; Lee, S.; Marks, D.; Merchant, A.; Stock, W.; Stelljes, M.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Relapsed and refractory Hodgkin lymphoma

Meeting Abstract

Moskowitz, A.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Treatment of marginal zone lymphoma

Meeting Abstract

Noy, A.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Primary mediastinal B-cell lymphoma

Meeting Abstract

Hamlin, P. A.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Efficacy and safety of defibrotide to treat hepatic veno-occlusive disease/sinusoidal obstruction Syndrome (VOD/SOS) After Primary Chemotherapy: A post hoc analysis of final data from an expanded-access protocol

Meeting Abstract

Kernan, N.; Antin, J.; Messinger, Y.; Liang, W.; Hume, R.; Tappe, W.; Richardson, P.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Timing of initiation of defibrotide post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final data from an expanded-access protocol

Meeting Abstract

Richardson, P.; Smith, A.; Antin, J.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; Tappe, W.; Kernan, N.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Day+100 survival and safety results from a defibrotide expanded-access program for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS): Final results

Meeting Abstract

Kernan, N.; Smith, A.; Antin, J.; Lehmann, L.; Giralt, S.; Ryan, R.; Hume, R.; Tappe, W.; Richardson, P.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Five-year efficacy and safety of dasatinib and imatinib by baseline comorbidity and age in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) from DASISION

Meeting Abstract

Mauro, M. J.; Cortes, J. E.; Hochhaus, A.; Shah, N. P.; Atallah, E. L.; Abaskharoun, M.; Sy, O.; Saglio, G.
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save